P-wave duration is a predictor for long-term mortality in post-CABG patients.
Sheila Tatsumi Kimura-MedorimaAna Paula Beppler Lazaro LinoMarcel P C AlmeidaMarcio Jansen de Oliveira FigueiredoLindemberg da Mota Silveira-FilhoPedro Paulo Martins de OliveiraOtavio Rizzi CoelhoJosé Roberto Matos SouzaWilson NadruzOrlando PetrucciAndrei Carvalho SpositoPublished in: PloS one (2018)
Risk stratification in secondary prevention has emerged as an unmet clinical need in order to mitigate the Number-Needed-to-Treat and make expensive therapies both clinically relevant and cost-effective. P wave indices reflect atrial conduction, which is a sensitive marker for inflammatory, metabolic, and pressure overload myocardial cell remodeling; the three stimuli are traditional mechanisms for adverse clinical evolution. Accordingly, we sought to investigate the predictive role of P-wave indices to estimate residual risk in patients with chronic coronary artery disease (CAD). The cohort included 520 post-Coronary Artery Bypass Grafting patients with a median age of 60 years who were followed for a median period of 1025 days. The primary endpoint was long-term all-cause death. Cubic spline model demonstrated a linear association between P-wave duration and incidence rate of long-term all-cause death (p = 0.023). P-wave >110ms was a marker for an average of 425 days shorter survival as compared with P-wave under 80ms (Logrank p = 0.020). The Cox stepwise regression models retained P-wave duration as independent marker (HR:1.37; 95%CI:1.05-1.79,p = 0.023). In conclusion, the present study suggests that P-wave measurement may constitute a simple, inexpensive and accessible prognostic tool to be added in the bedside risk estimation in CAD patients.
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- end stage renal disease
- chronic kidney disease
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- mass spectrometry
- cardiovascular events
- oxidative stress
- ms ms
- prognostic factors
- stem cells
- risk factors
- left ventricular
- heart failure
- cell therapy
- patient reported
- mitral valve
- left atrial
- free survival
- neural network
- electronic health record